148 related articles for article (PubMed ID: 16160601)
1. Rapamycin attenuates atherosclerotic plaque progression in apolipoprotein E knockout mice: inhibitory effect on monocyte chemotaxis.
Pakala R; Stabile E; Jang GJ; Clavijo L; Waksman R
J Cardiovasc Pharmacol; 2005 Oct; 46(4):481-6. PubMed ID: 16160601
[TBL] [Abstract][Full Text] [Related]
2. Oral rapamycin inhibits growth of atherosclerotic plaque in apoE knock-out mice.
Waksman R; Pakala R; Burnett MS; Gulick CP; Leborgne L; Fournadjiev J; Wolfram R; Hellinga D
Cardiovasc Radiat Med; 2003; 4(1):34-8. PubMed ID: 12892771
[TBL] [Abstract][Full Text] [Related]
3. Rapamycin attenuates atherosclerosis induced by dietary cholesterol in apolipoprotein-deficient mice through a p27 Kip1 -independent pathway.
Castro C; Campistol JM; Sancho D; Sánchez-Madrid F; Casals E; Andrés V
Atherosclerosis; 2004 Jan; 172(1):31-8. PubMed ID: 14709354
[TBL] [Abstract][Full Text] [Related]
4. The anti-inflammatory vasostatin-2 attenuates atherosclerosis in ApoE
Xiong W; Wang X; Dai D; Zhang B; Lu L; Tao R
Thromb Haemost; 2017 Jan; 117(2):401-414. PubMed ID: 27831589
[TBL] [Abstract][Full Text] [Related]
5. Deficiency in lymphotoxin β receptor protects from atherosclerosis in apoE-deficient mice.
Grandoch M; Feldmann K; Göthert JR; Dick LS; Homann S; Klatt C; Bayer JK; Waldheim JN; Rabausch B; Nagy N; Oberhuber A; Deenen R; Köhrer K; Lehr S; Homey B; Pfeffer K; Fischer JW
Circ Res; 2015 Apr; 116(8):e57-68. PubMed ID: 25740843
[TBL] [Abstract][Full Text] [Related]
6. Propagermanium reduces atherosclerosis in apolipoprotein E knockout mice via inhibition of macrophage infiltration.
Yamashita T; Kawashima S; Ozaki M; Namiki M; Inoue N; Hirata K; Yokoyama M
Arterioscler Thromb Vasc Biol; 2002 Jun; 22(6):969-74. PubMed ID: 12067906
[TBL] [Abstract][Full Text] [Related]
7. Direct effect of an acyl-CoA:cholesterol acyltransferase inhibitor, F-1394, on atherosclerosis in apolipoprotein E and low density lipoprotein receptor double knockout mice.
Chiwata T; Aragane K; Fujinami K; Kojima K; Ishibashi S; Yamada N; Kusunoki J
Br J Pharmacol; 2001 Aug; 133(7):1005-12. PubMed ID: 11487509
[TBL] [Abstract][Full Text] [Related]
8. Uremia accelerates both atherosclerosis and arterial calcification in apolipoprotein E knockout mice.
Massy ZA; Ivanovski O; Nguyen-Khoa T; Angulo J; Szumilak D; Mothu N; Phan O; Daudon M; Lacour B; Drüeke TB; Muntzel MS
J Am Soc Nephrol; 2005 Jan; 16(1):109-16. PubMed ID: 15563564
[TBL] [Abstract][Full Text] [Related]
9. Endothelin-1 overexpression exacerbates atherosclerosis and induces aortic aneurysms in apolipoprotein E knockout mice.
Li MW; Mian MO; Barhoumi T; Rehman A; Mann K; Paradis P; Schiffrin EL
Arterioscler Thromb Vasc Biol; 2013 Oct; 33(10):2306-15. PubMed ID: 23887640
[TBL] [Abstract][Full Text] [Related]
10. Broad-spectrum CC-chemokine blockade by gene transfer inhibits macrophage recruitment and atherosclerotic plaque formation in apolipoprotein E-knockout mice.
Bursill CA; Choudhury RP; Ali Z; Greaves DR; Channon KM
Circulation; 2004 Oct; 110(16):2460-6. PubMed ID: 15477414
[TBL] [Abstract][Full Text] [Related]
11. Angiotensin AT1 receptor antagonist irbesartan decreases lesion size, chemokine expression, and macrophage accumulation in apolipoprotein E-deficient mice.
Dol F; Martin G; Staels B; Mares AM; Cazaubon C; Nisato D; Bidouard JP; Janiak P; Schaeffer P; Herbert JM
J Cardiovasc Pharmacol; 2001 Sep; 38(3):395-405. PubMed ID: 11486244
[TBL] [Abstract][Full Text] [Related]
12. Effect of sirolimus on the cholesterol content of aortic arch in ApoE knockout mice.
Basso MD; Nambi P; Adelman SJ
Transplant Proc; 2003 Dec; 35(8):3136-8. PubMed ID: 14697997
[TBL] [Abstract][Full Text] [Related]
13. Oral rapamycin attenuates atherosclerosis without affecting the arterial responsiveness of resistance vessels in apolipoprotein E-deficient mice.
Gadioli AL; Nogueira BV; Arruda RM; Pereira RB; Meyrelles SS; Arruda JA; Vasquez EC
Braz J Med Biol Res; 2009 Dec; 42(12):1191-5. PubMed ID: 19893993
[TBL] [Abstract][Full Text] [Related]
14. Low-dose oral sirolimus reduces atherogenesis, vascular inflammation and modulates plaque composition in mice lacking the LDL receptor.
Zhao L; Ding T; Cyrus T; Cheng Y; Tian H; Ma M; Falotico R; Praticò D
Br J Pharmacol; 2009 Mar; 156(5):774-85. PubMed ID: 19220291
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of sphingomyelin synthesis reduces atherogenesis in apolipoprotein E-knockout mice.
Park TS; Panek RL; Mueller SB; Hanselman JC; Rosebury WS; Robertson AW; Kindt EK; Homan R; Karathanasis SK; Rekhter MD
Circulation; 2004 Nov; 110(22):3465-71. PubMed ID: 15545514
[TBL] [Abstract][Full Text] [Related]
16. Vulnerable atherosclerotic plaque morphology in apolipoprotein E-deficient mice unable to make ascorbic Acid.
Nakata Y; Maeda N
Circulation; 2002 Mar; 105(12):1485-90. PubMed ID: 11914259
[TBL] [Abstract][Full Text] [Related]
17. Temporal relationships between circulating levels of CC and CXC chemokines and developing atherosclerosis in apolipoprotein E*3 Leiden mice.
Murphy N; Bruckdorfer KR; Grimsditch DC; Overend P; Vidgeon-Hart M; Groot PH; Benson GM; Graham A
Arterioscler Thromb Vasc Biol; 2003 Sep; 23(9):1615-20. PubMed ID: 12842836
[TBL] [Abstract][Full Text] [Related]
18. Ticlopidine attenuates progression of atherosclerosis in apolipoprotein E and low density lipoprotein receptor double knockout mice.
Jawien J; Csanyi G; Gajda M; Mateuszuk L; Lomnicka M; Korbut R; Chlopicki S
Eur J Pharmacol; 2007 Feb; 556(1-3):129-35. PubMed ID: 17174298
[TBL] [Abstract][Full Text] [Related]
19. Effect of macrophage-derived apolipoprotein E on hyperlipidemia and atherosclerosis of LDLR-deficient mice.
Shi W; Wang X; Wong J; Hedrick CC; Wong H; Castellani LW; Lusis AJ
Biochem Biophys Res Commun; 2004 Apr; 317(1):223-9. PubMed ID: 15047172
[TBL] [Abstract][Full Text] [Related]
20. Hydrogen sulfide regulates vascular endoplasmic reticulum stress in apolipoprotein E knockout mice.
Chen ZF; Zhao B; Tang XY; Li W; Zhu LL; Tang CS; DU JB; Jin HF
Chin Med J (Engl); 2011 Nov; 124(21):3460-7. PubMed ID: 22340159
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
